Koers Shenzhen Salubris Pharmaceuticals Co., Ltd.
Aandelen
002294
CNE100000FW8
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
30,91 CNY | +3,14% | +7,29% | -5,36% |
Omzet 2024 * | 3,92 mld. 542 mln. 507 mln. | Omzet 2025 * | 4,74 mld. 654 mln. 613 mln. | Marktkapitalisatie | 34,12 mld. 4,71 mld. 4,41 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 674 mln. 93,02 mln. 87,1 mln. | Nettowinst (verlies) 2025 * | 826 mln. 114 mln. 107 mln. | EV/omzet 2024 * | 7,88 x |
Nettoliquiditeiten 2024 * | 3,2 mld. 441 mln. 413 mln. | Nettoliquiditeiten 2025 * | 3,18 mld. 438 mln. 411 mln. | EV/omzet 2025 * | 6,53 x |
K/w-verhouding 2024 * |
51,8
x | K/w-verhouding 2025 * |
41,8
x | Werknemers | 3.517 |
Dividendrendement 2024 * |
1,71% | Dividendrendement 2025 * |
1,41% | Vrij verhandelbaar | 38,31% |
1 dag | +3,14% | ||
1 week | +7,29% | ||
Lopende maand | +6,18% | ||
1 maand | +14,06% | ||
3 maanden | +6,96% | ||
6 maanden | +6,15% | ||
Lopend jaar | -5,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jie Yan
CEO | Chief Executive Officer | 51 | 01-01-06 |
Ai Zhen Li
CHM | Chairman | 54 | 01-03-04 |
Yun Kong
DFI | Director of Finance/CFO | 51 | 01-10-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Cheng Hai Ye
BRD | Director/Board Member | 80 | 03-11-98 |
Sing Ye
CHM | Chairman | 49 | 01-07-04 |
Jian Feng Yang
BRD | Director/Board Member | 48 | 01-01-06 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.63% | 2 M€ | -16,59% | - | |
0.46% | 2 M€ | -14,14% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 31,26 | +1,13% | 4 966 779 |
25-04-24 | 30,91 | +3,14% | 5 639 419 |
24-04-24 | 29,97 | -1,90% | 5 871 349 |
23-04-24 | 30,55 | +6,08% | 8 764 717 |
22-04-24 | 28,8 | +2,38% | 3 833 716 |
slotkoers Shenzhen S.E., 25 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,36% | 4,66 mld. | |
+19,62% | 43,78 mld. | |
+20,44% | 21,89 mld. | |
+10,86% | 14,45 mld. | |
+13,07% | 13,63 mld. | |
+37,46% | 11,49 mld. | |
-8,59% | 6,85 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+6,35% | 5,06 mld. |